Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Goodwill bin find in Oklahoma City leads to diploma return
An Oklahoma TikToker who found a 1954 high school...
North Korea calls the US push for its denuclearization ‘anachronistic dream’
SEOUL, South Korea -- SEOUL, South Korea (AP) —...
Drier and hotter conditions move into New Mexico to end the weekend
Another round of showers and storms developed across the...